Skip to main content
    • Aa
    • Aa

Effectiveness of 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in otomycosis patients: a randomised, controlled trial

  • S Romsaithong (a1), K Tomanakan (a2), W Tangsawad (a1) and S Thanaviratananich (a3)

To compare the clinical effectiveness and adverse events for 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in the treatment of otomycosis.


A total of 120 otomycosis patients were randomly assigned to receive either 1 per cent clotrimazole solution (intervention group) or 3 per cent boric acid in 70 per cent alcohol (control group) at the Khon Kaen Hospital ENT out-patient department. Treatment effectiveness was determined based on the otomicroscopic absence of fungus one week after therapy, following a single application of treatment.


After 1 week of treatment, there were data for 109 participants, 54 in the clotrimazole group and 55 in the boric acid group. The absolute difference in cure rates between 1 per cent clotrimazole solution and 3 per cent boric acid in 70 per cent alcohol was 17.9 per cent (95 per cent confidence interval, 2.3 to 33.5; p = 0.028) and the number needed to treat was 6 (95 per cent confidence interval, 3.0 to 43.4). Adverse events for the two agents were comparable.


One per cent clotrimazole solution is more effective than 3 per cent boric acid in 70 per cent alcohol for otomycosis treatment.

Corresponding author
Address for correspondence: Dr Sanguansak Thanaviratananich, Department of Otorhinolaryngology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Fax: +66 43 202 490 E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2 R Munguia , SJ. Daniel Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol 2008;72:453–9

3 I Vennewald , E. Klemm Otomycosis: diagnosis and treatment. Clin Dermatol 2010;28:202–11

4 A del Palacio , MS Cuetara , MJ Lopez-Suso , E Amor , M. Garau Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. Mycoses 2002;45:317–28

6 T Ho , JT Vrabec , D Yoo , NJ. Coker Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg 2006;135:787–91

7 KM Ozcan , M Ozcan , A Karaarslan , F. Karaarslan Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol 2003;117:3942

10 J Chander , S Maini , S Subrahmanyan , A. Handa Otomycosis–a clinico-mycological study and efficacy of mercurochrome in its treatment. Mycopathologia 1996;135:912

11 WB. Hurst Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol 2001;115:879–80

12 N Mgbor , HC. Gugnani Otomycosis in Nigeria: treatment with mercurochrome. Mycoses 2001;44:395–7

14 VJ Jadhav , M Pal , GS. Mishra Etiological significance of Candida albicans in otitis externa. Mycopathologia 2003;156:313–15

15 A Jackman , R Ward , M April , J. Bent Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol 2005;69:857–60

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 6
Total number of PDF views: 81 *
Loading metrics...

Abstract views

Total abstract views: 562 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 28th April 2017. This data will be updated every 24 hours.